申请人:——
公开号:US20040127576A1
公开(公告)日:2004-07-01
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant inventive are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restinosis, gynecomastia, autoimmune disease, vascular smooth muscle cell proliferation, obesity, incontinence, and cancer of the lung, colon, breast, uterus, and prrostate.
本发明涉及化合物及其衍生物,它们的合成以及它们作为雌激素受体调节剂的用途。本发明的化合物是雌激素受体的配体,因此可能对与雌激素功能相关的多种疾病的治疗或预防有用,包括骨质流失、骨折、骨质疏松、软骨退化、子宫内膜异位症、子宫肌瘤疾病、潮热、低密度脂蛋白胆固醇水平升高、心血管疾病、认知功能障碍、脑退行性疾病、再狭窄、男性乳腺发育、自身免疫性疾病、血管平滑肌细胞增殖、肥胖、失禁以及肺、结肠、乳房、子宫和前列腺癌。